BRANDY RAMBIN: Open Payments
NPI 1235513151 · SHREVEPORT, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,829 in 54 payments from 18 companies in 2025. Trend: 2023 $1,156 · 2024 $1,061 · 2025 $1,829
Food & beverage: $1,829
| Company | Payments | Amount |
|---|---|---|
| AOP Health US, LLC | 1 | $925 |
| Novartis Pharmaceuticals Corporation | 14 | $236 |
| PFIZER INC. | 7 | $111 |
| Merck Sharp & Dohme LLC | 6 | $108 |
| Stryker Corporation | 4 | $67 |
| Kestra Medical Technology Services, Inc. | 3 | $63 |
| Inari Medical, Inc. | 2 | $54 |
| E.R. Squibb & Sons, L.L.C. | 2 | $38 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $34 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $30 |
Products named: Rapiblyk, LEQVIO, ELIQUIS, VERQUVO, FLOWTRIEVER CATHETER, S, Assure WCD, Kerendia, JARDIANCE.
Industry payments across LA — which companies pay providers there.
